Accurate detection of cerebral microbleeds (CMBs) is incredibly important for the proper diagnosis of several neurodegenerative diseases, but these small bleeds are often missed or misinterpreted with conventional imaging. Particularly when diagnosing TBI, stroke or dementia, the ability to quickly and accurately identify and quantify CMBS can make all the difference in the world in a patient’s treatment plan.
Join us for our upcoming live webinar on Tuesday, September 22nd at 12PM EST to learn about SpinTech’s new automatic CMB detection and quantification tool, bringing practical applications of AI to solve common clinical challenges. Ward Detwiler, President & CEO of SpinTech, and Miller Fawaz, Sr. Research Engineer of Magnetic Resonance Innovations, will be discussing the clinical applications of STAGE, SpinTech’s rapid, multi-contrast MRI software tool, and presenting real world cases using STAGE-CMB.
Attendees will learn about:
- The clinical applications of SpinTech’s automated CMB detection tool for TBI, stroke and dementia
- How our CMB tool may improve detection rates, reduce read times, and improve workflow efficiency
- How using enhanced MR protocols and automated detection tools can improve clinical decision-making, allowing for proper CMB identification and quantification, which is directly correlated with long-term cognitive outcomes